ArticleCureus2025
Is Bipolar Radiofrequency Thermotherapy a Reliable Treatment for Benign Prostatic Hyperplasia in Elderly Patients Ineligible for General and Spinal Anesthesia?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The objective of this study was to investigate the success and safety of bipolar radiofrequency thermotherapy in the treatment of benign prostatic hyperplasia (BPH) in elderly patients ineligible for general and spinal anesthesia owing to significant comorbidities. Methods A total of 115 patients were included in the study. The cohort consisted of patients who had BPH refractory to medical treatment along with excessive comorbidities, rendering them unsuitable for general and spinal anesthesia. Patients with preoperative diagnoses of prostate cancer, urethral stricture, median lobe, neurogenic bladder, or psychological disorders were excluded from the study. Prostate-specific antigen (PSA), International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), post-void residual (PVR), and quality of life (QoL) were reassessed, and prostate volume was measured at postoperative months 3 and 12. Preoperative values were compared with values measured at postoperative months 3 and 12. Perioperative complications were assessed according to the Clavien-Dindo Scoring System. Results The median age of the patients was 73.71 ± 11.23 years (mean ± SD). Comparison of the preoperative values of prostate volume, PSA, IPSS, Qmax, PVR, and QoL with values measured at postoperative months 3 and 12 showed a significant reduction in prostate volume (p=0.001), significant improvement in IPSS (p=0.001), a significant increase in Qmax (p=0.001), a significant decrease in PVR (p=0.001), and significant improvement in QoL (p=0.01). However, no significant change was noted in PSA values (p=0.976). The VAS score was 4 ± 1 (0-10) at postoperative hour 1. In the early postoperative period (30 days), urinary retention was observed in seven patients (6.08%), and urinary tract infection in four patients (3.4%). Clavien grade 4 or grade 5 complications were not observed. Conclusions Bipolar radiofrequency thermotherapy is a successful and safe method for the treatment of BPH in elderly patients who are ineligible for spinal or general anesthesia due to excessive comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.